Health Day News: Adipose Tissue Insulin Resistance Up in Obese-NGT, IGT, T2DM

December 30, 2016

Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), according to a study published online Jan. 4 in Diabetes. Read the full story at Health Day News



Diabetic foot treatment is focus of Dec. 8-10 conference

December 2, 2016

Attention, health care providers with interest in surgical management of the diabetic foot: The UT Health Science Center at San Antonio announces the 11th Annual International External Fixation Symposium, set for Dec. 8-10 at the La Cantera Hill Country Resort. Registration is still open for this multidisciplinary continuing education conference, which will feature state-of-the-art lectures […]

diabetes in men


AJMC.com: As Metformin Combinations Proliferate, Questions Arise About Value

September 10, 2016

Earlier this year, when the FDA granted initial approval to Jentadueto XR and a first-line indication to Invokamet, it gave fresh momentum to an entire category of medications: single pills that combine metformin with some other treatment for type 2 diabetes (T2D).  – See more at: http://www.ajmc.com/journals/evidence-based-diabetes-management/2016/september-2016/as-metformin-combinations-proliferate-questions-arise-about-value#sthash.jAAOQ94L.dpuf Read the full story at AJMC.com